Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated
pathology, COVID-19, have been of particular concerns these last months due to the …

Although numerous clinical trials have been implemented, an absolutely effective treatment
against coronavirus disease 2019 (COVID-19) is still elusive. Interleukin-22 (IL-22) has …

Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis.
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …

Introduction Severe COVID-19 cases have a detrimental hyper-inflammatory host response
and different cytokine-blocking biologic agents were explored to improve outcomes …

Objective Increasing evidence points to endothelial dysfunction as a key pathophysiological
factor in coronavirus disease-2019 (COVID-19). No specific methods have been identified to …

Background: Biomarkers that would help prognosticate outcomes and guide treatment of
patients with severe coronavirus disease 2019 (COVID-19) are currently required. We aimed …

Previously, I suggested that arachidonic acid (AA, 20: 4 n-6) and similar bioactive lipids
(BALs) inactivate SARS-CoV-2 and thus, may be of benefit in the prevention and treatment …

Neutrophils and COVID-19: Nots, NETs, and knots | Journal of Experimental Medicine |
Rockefeller University Press Skip to Main Content Advertisement Umbrella Alt Text …

GM-CSF acts as a pro-inflammatory cytokine and a key growth factor produced by several
immune cells such as macrophages and activated T cells. In this review, we discuss recent …

Sepsis is a syndrome with high mortality, which seriously threatens human health. During
the pandemic of coronavirus disease 2019 (COVID-19), some severe and critically ill COVID …